Inhibition of parathormone-stimulated bone resorption by type I interferon.
The effect of Type I interferon on bone resorption was studied by measuring its effect on parathormone-stimulated calcium release from neonatal murine calvaria in vitro. A pure human recombinant leukocyte interferon hybrid of the A and D subtypes was used, which has high antiviral activity on mouse cells. Calcium release was inhibited in a dose dependent fashion with 50% inhibition at about 10(-10) M or 600 U/ml, and the inhibition was reversible. The presence of interferon was required before or during the activation phase of the resorptive response, when the formation of osteoclasts from precursor cells would occur. When added to actively resorbing bone it had no effect. The data suggest that Type I interferon can inhibit the parathormone-regulated development of active osteoclasts, possibly by inhibiting osteoclast precursor differentiation.
D000818:Animals; D001862:Bone Resorption / Q000187:drug effects*; D001842:Bone and Bones / Q000502:physiology; D002116:Calcitonin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D007370:Interferon Type I / Q000494:pharmacology*; D007700:Kinetics; D051379:Mice; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors*
D007370:Interferon Type I; D010281:Parathyroid Hormone; D002116:Calcitonin; D002118:Calcium